Immunological fluctuations during intrathecal immunotherapy in three patients affected by CNS tumours disseminating via CSF. (Q48095420)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7989157%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Immunological fluctuations during intrathecal immunotherapy in three patients affected by CNS tumours disseminating via CSF (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7989157%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7989157%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Emilio Ciusani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7989157%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

author name string

A Salmaggi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7989157%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A Dufour

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7989157%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A Nespolo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7989157%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A Boiardi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7989157%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

publication date

1 July 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7989157%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Neuroscience

30 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7989157%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7989157%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7989157%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

117-125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7989157%20AND%20SRC:MED&resulttype=core&format=json

Lymphokines and cytokines as cancer treatment. Immunotherapy realized

30 October 2019

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00207459408986024

Immunobiology of primary intracranial tumors. Part 10: Therapeutic efficacy of interferon in the treatment of recurrent gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459408986024

Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459408986024

Delayed neurotoxicity of intraventricular interleukin-2: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459408986024

The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459408986024

Responses of human glioblastoma cells to human natural tumor necrosis factor-alpha: susceptibility, mechanism of resistance and cytokine production studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459408986024

Effects of recombinant human tumor necrosis factor-alpha on the surface phenotype and the growth of human malignant glioma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459408986024

Clinical effect of intra-arterial tumor necrosis factor-alpha for malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459408986024

10.3109/00207459408986024

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7989157%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference